Author: BRIVARK
-
Making evidence go further: Advancing synergy between agent – based modeling and randomized control trials
-
Increasing the Varieties of Marijuana and Marijuana products for Research
The CESC is a non-profit organization with a mission to align Cannabis science, clinical practice, and public policy to ensure best outcomes. Our initial observation of the marijuana varieties used in states with medical cannabis laws noted higher levels of THC and CBD than the varieties available in the marijuana plant material of the NIDA… Read more
-
Journal of Drug Policy Analysis
AN ANALYSIS OF APPLICANTS PRESENTING TO A MEDICAL MARIJUANA SPECIALTY PRACTICE IN CALIFORNIA Read more
-
Report on Cannabidiol: Considerations for use in wellness and in treatment of specific illness
After 80 years of prohibition, Cannabis Sativa is being accepted on a worldwide scale for medicinal and general consumption. As consequence, investigations into CBD’s effects have begun. There is much to learn about CBD. Particularly, studies are necessary on best presentation and dosage per indication. At this point, we know CBD is not causing serious adverse effect. Thus,… Read more
-
The Dosing ProjectTM Proof of Concept Phase
At the turn of the 21st century, Cannabis use was again permitted and has spread throughout the globe. The Dosing Project™ is a crowd-sourced surveillance tool that takes advantage of a depth of historical use in order to understand Cannabis dosage, anticipated effects and adverse events. The Dosing Project™ surveys Cannabis users to inform on… Read more
-
Society of General Internal Medicine – Medical Marijuana
I first began recommending cannabis regularly in 2004. That year, a federal District Court decision (Conant vs. Walters) upheld an appeal allowing physicians the freedom to recommend cannabis as medical treatment.1 We could recommend cannabis use to patients as long as we performed a good faith evaluation and didn’t “aid and abet” in the still… Read more
-
Radicle Aces (Advancing CBD Education & Science)
Radicle ACES is the first multi-brand, Institutional Review Board-approved randomized controlled trial to evaluate the effectiveness of commercially available CBD products. We recruited 3000 participants from across the United States who reported symptoms of anxiety, sleep disturbance, or long-term pain, and randomized them to receive a 4-week supply of 1 of 13 different commercially available… Read more
-
Artificial Intelligence For Craft Cannabis
Extraction artists need help. While Big Data is nearly everywhere in the cannabis industry, extraction is still stuck in the last century. However, Artificial Intelligence is not the Savior of all. Data by itself is meaningless, incomplete, and devoid of solutions. Read more
-
Solving Cannabis Consistency
The cannabis edibles and THC beverage industries struggle with consistency and bioavailability problems.This paper outlines the real and measurable benefits of using nanoemulsions in the newly growing ediblemarketplace. It examines the pharmacokinetic testing data, science, and research behind the latest advances innanoemulsion technology and explores how nanoemulsions can provide greater bioavailability and improvedconsistency for hemp… Read more
-
Case Study: Metastatic Breast Cancer In Remission
A 49-year-old woman was diagnosed with an ER+, PR-, HER2+, BRCA- De Novo metastatic breast cancer including bone, liver, and lymph node involvement. Standardized care included a five-month treatment period with targeted chemotherapy and radiotherapy, and a ketogenic diet. The patient also began a course of whole plant cannabinoid-based therapy and psilocybin-assisted psychotherapy at macro… Read more